We provide comprehensive, physician‑directed metabolic and weight management care delivered through a personalized, high‑touch experience.

Services include medical weight management with GLP‑1 therapy when clinically appropriate, individualized nutrition guidance, strength‑focused lifestyle planning, and ongoing medication management. Each care plan is evidence‑based and designed for sustainable, long‑term results.

This is structured medical care with continuity and discretion — not a one‑time prescription service.

Schedule your telehealth visit and complete a secure intake followed by a physician evaluation. If appropriate, you’ll agree on a personalized treatment plan before any prescription is issued.

A payment method is required to reserve your appointment but is not charged until your plan is finalized. Lab monitoring may be required when indicated.

Medication is dispensed by a state-licensed 503A compounding pharmacy and shipped directly to you, with typical delivery in 5–14 business days. Ongoing follow-up and dose adjustments are managed under physician supervision.

GLP-1 medications work by mimicking a naturally occurring hormone involved in appetite regulation and blood sugar control.

They help slow gastric emptying, enhance insulin signaling, and influence areas of the brain that regulate hunger and satiety. For many individuals, this results in improved appetite control and reduced caloric intake.

These medications are intended to be used as part of a structured, physician-directed treatment plan when clinically appropriate.

Weight loss outcomes vary from person to person and depend on factors such as baseline metabolic health, adherence to the treatment plan, lifestyle patterns, and duration of therapy. GLP-1 medications support appetite regulation and metabolic signaling, but they are not a quick-fix solution.

Some patients notice changes in appetite within the first several weeks, while measurable weight loss typically occurs gradually over time. Dosing is carefully titrated to balance effectiveness and tolerability, and progress is assessed during follow-up visits with adjustments made as clinically appropriate.

Specific outcomes cannot be guaranteed, as treatment plans are individualized based on each patient’s clinical response.

GLP-1 therapy is designed to support long-term metabolic health and appetite regulation when clinically appropriate—it is not a quick fix. Sustainable results are achieved through a structured approach with ongoing medical oversight and individualized treatment focused on gradual, clinically sound progress.

These medications are intended to complement—not replace—nutrition and physical activity. While GLP-1 therapy may help regulate appetite, long-term success is best supported by healthy dietary habits, regular movement, and continued medical guidance.

Your treatment plan is personalized and may include lifestyle recommendations tailored to your health goals.

No. While nutrition, activity, and lifestyle habits are important, research shows that body weight is influenced by complex biological factors — including genetics, hormonal signaling, metabolism, and appetite regulation.

For some individuals, these physiologic mechanisms make weight loss significantly more challenging, even with sustained effort.

Medical weight management addresses these underlying factors in a structured, physician-directed manner — supporting sustainable progress rather than relying on willpower alone.

GLP-1 medications in their FDA-approved, branded forms have been studied and approved for specific medical indications. Compounded GLP-1 medications are not FDA-approved products and are prepared by state-licensed compounding pharmacies pursuant to patient-specific prescriptions, as permitted under applicable federal and state laws.

As with any prescription medication, potential risks and side effects may occur. Common side effects are typically gastrointestinal—such as nausea, mild stomach discomfort, constipation, or decreased appetite—especially during early treatment, and often improve as the body adjusts.

Treatment is based on an individualized medical evaluation, with dosing carefully titrated to balance effectiveness and tolerability. Ongoing monitoring and follow-up care are provided, and any side effects are addressed promptly under physician supervision.

GLP-1 medications may not be appropriate for individuals with certain medical conditions or risk factors, including a personal or family history of specific endocrine disorders, pancreatitis, or certain gastrointestinal conditions.

Eligibility is determined through a comprehensive physician evaluation to ensure safe and appropriate use. While many individuals with existing conditions may still qualify, some may require additional evaluation or may not be candidates for treatment.

Baseline laboratory testing may be required if recent results are not available. Ongoing monitoring is ordered when clinically indicated to ensure safe and appropriate treatment.

Low Country Recovery operates on a direct-pay model and does not bill insurance.

This allows for structured, physician-directed care without third-party restrictions. All costs are reviewed transparently during your consultation prior to initiating treatment.

Telehealth prescribing can be appropriate when conducted in accordance with state and federal regulations and when supported by a comprehensive medical evaluation.

At Low Country Recovery, all patients complete a physician-directed telehealth assessment prior to any treatment decision. Prescriptions are issued only when clinically appropriate and in compliance with applicable prescribing guidelines.

Telehealth allows for structured, ongoing follow-up while maintaining medical oversight and patient safety.

The duration of GLP-1 treatment varies based on your individual goals, clinical response, and overall health profile. These medications are not intended as a short-term or quick-fix solution, and for many individuals, sustainable results require an ongoing, structured approach.

Your care is individualized, and treatment plans are reviewed regularly and adjusted based on your progress and preferences in collaboration with your physician.

If GLP-1 therapy is discontinued, appetite regulation may gradually return to baseline over time, and some individuals may experience an increase in appetite. Weight outcomes after discontinuation can vary and are influenced by factors such as lifestyle habits, metabolic health, and duration of therapy.

If discontinuation is being considered, it should be discussed with your physician so an appropriate plan can be developed to support a smooth transition.

If you experience side effects that do not improve with dose adjustment, your treatment plan will be reassessed.

Dosing can often be modified, slowed, or paused to improve tolerability. If a medication is not a good fit, alternative options or strategies may be discussed based on your clinical profile and goals.

Your care is individualized, and treatment continues only when it remains both appropriate and well tolerated.

A compounding pharmacy is a state-licensed pharmacy that prepares customized medications tailored to an individual patient’s needs, such as specific dosing strengths or formulations that may not be commercially available.

Compounded medications are prepared by licensed 503A compounding pharmacies pursuant to a valid, patient-specific prescription and in accordance with applicable federal and state regulations. Low Country Recovery prescribes only following an individualized physician evaluation and utilizes state-licensed U.S. compounding pharmacies, including established providers such as Hallandale, Empower, Red Rock, and Strive.

Compounded medications are not FDA-approved products and are not reviewed by the FDA in the same manner as commercially manufactured drugs. When clinically appropriate, compounding may allow for individualized dosing as determined by your physician.